Mental Health

Results from Social Listening Analysis and Survey of People with Narcolepsy Uncover Real-Life Challenges with Twice-Nightly Oxybate Therapy

– Findings published in Brain Sciences showed missed doses and potential for injury when waking to take a second dose...

Reunion Neuroscience Presented RE104 Phase 1 Data at the 2024 American College of Neuropsychopharmacology (ACNP) 63rd Annual Meeting

MORRISTOWN, N.J., Dec. 11, 2024 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc., a clinical-stage biopharmaceutical company committed to revolutionizing the treatment...

HMNC Brain Health Collaborates with the Austrian Institute of Technology and the Danube Private University to Win Grant from the Austrian Research Promotion Agency

Grant for "Personalized Medicine Enabled by Intelligent Sensing Systems” ProjectMUNICH, Dec. 11, 2024 (GLOBE NEWSWIRE) -- HMNC Brain Health, a...

ON THE 37TH ANNIVERSARY OF HER LIFE’S WORK, VIOLENCE PREVENTION PIONEER AND “PEACE DOCTOR” ERICA FORD RELEASES A “PLAYBOOK” FOR CULTIVATING PEACE

NEW YORK, Dec. 10, 2024 /PRNewswire/ -- Amid escalating mental health challenges and societal divisions, renowned human rights activist and violence...

U.S. Top Medical Doctors Partner With Known Co-Founder Kourtney Simmang to Launch Kale Health: A Functional Health Innovation

Bridging functional health with top-tier medical expertise, Kale Health introduces a comprehensive, client-centered approach to modern care. DALLAS, TX /...

Vital Data Technology Announces Agreement with Mid-State Health Network to Provide Predictive Models for Mental Health and Substance Use Disorders

NEWPORT BEACH, Calif., Dec. 10, 2024 /PRNewswire/ -- Vital Data Technology, a leading provider of AI-driven health data analytics and...

Poster Presentation Describing the Significant Results of Crofelemer for Cancer Therapy-Related Diarrhea (CTD) in Breast Cancer Patients to Take Place December 11, 2024 at San Antonio Breast Cancer Symposium (SABCS)

error: Content is protected !!